Immediate Impact
5 standout
Citing Papers
Hepatocellular carcinoma: signaling pathways and therapeutic advances
2025 Standout
Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective
2024 Standout
Works of Kateryna Shmanko being referenced
Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Kateryna Shmanko | 16 | 2 | 2 | 45 | 25 | 3 | 58 | |
| Friedrich Sinner | 6 | 2 | 28 | 13 | 3 | 35 | ||
| Brenda Hernandez | 11 | 6 | 24 | 15 | 2 | 42 | ||
| Mathieu Vaillant | 13 | 3 | 1 | 42 | 17 | 5 | 173 | |
| Guoliang Shao | 8 | 2 | 28 | 10 | 4 | 44 | ||
| M.A. Varona | 30 | 6 | 43 | 25 | 4 | 57 | ||
| Brian Kim-Poh Goh | 32 | 2 | 39 | 11 | 3 | 57 | ||
| Alberto Vásquez | 45 | 4 | 34 | 20 | 3 | 95 | ||
| Hamdi A. Ali | 21 | 1 | 34 | 39 | 5 | 63 | ||
| Fariborz Mansour-Ghanaei | 17 | 11 | 19 | 13 | 2 | 60 | ||
| Yuwa Ando | 5 | 2 | 1 | 44 | 7 | 5 | 59 |
All Works
Login with ORCID to disown or claim papers
Loading papers...